CoChat

Inflammation and metabolic cardiomyopathy

Nishida, Kazuhiko, Otsu, Kinya · 2017 · Cardiovascular Research

The DOI matches its Crossref record; 115 of the 117 references it cites were found in a registry or an index.

Abstract

Excessive feeding is associated with an increase in the incidence of chronic metabolic diseases, such as obesity, insulin resistance, and type 2 diabetes. Metabolic disturbance induces chronic low-grade inflammation in metabolically-important organs, such as the liver and adipose tissue. Many of the inflammatory signalling pathways are directly triggered by nutrients. The pro-inflammatory mediators in adipocytes and macrophages infiltrating adipose tissue promote both local and systemic pro-inflammatory status. Metabolic cardiomyopathy is a chronic metabolic disease characterized by structural and functional alterations and interstitial fibrosis without coronary artery disease or hypertension. In the early stage of metabolic cardiomyopathy, metabolic disturbance is not accompanied by substantial changes in myocardial structure and cardiac function. However, metabolic disturbance induces subcellular low-grade inflammation in the heart, and in turn, subcellular component abnormalities, such as oxidative stress, mitochondrial dysfunction, endoplasmic reticulum stress, and impaired calcium handling, leading to impaired myocardial relaxation. In the advanced stage, the vicious cycle of subcellular component abnormalities, inflammatory cell infiltration, and neurohumoral activation induces cardiomyocyte injury and death, and cardiac fibrosis, resulting in impairment of both diastolic and systolic functions. This review discusses some recent advances in understanding involvement of inflammation in metabolic cardiomyopathy.

Overview

Integrity signals

Registry

Crossref · 10.1093/cvr/cvx012

Cites

115 of 115 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 115 references

Cited by

See all 329

Metadata

Authors
Nishida, K., & Otsu, K.
Corresponding author
Otsu, Kinya
Venue
Cardiovascular Research
Published
2017-03-03
Volume
113
Issue
4
Pages
389-398
ISSN
  • 0008-6363 (ISSN-L)
  • 1755-3245
OpenAlex
W2593856047
Cited by
329
References
117
Citations by year
2026: 22 · 2025: 40 · 2024: 58 · 2023: 45 · 2022: 35 · 2021: 36 · 2020: 28 · 2019: 26 · 2018: 22 · 2017: 17
FWCI
3.56
Type
journal article
Language
en
Open access
closed
Locations
  • Cardiovascular Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • British Heart Foundation (CH/11/3/29051, RG/11/12/29052)
  • King’s BHF Centre of Excellence (2E/08/003)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords
metabolic cardiomyopathy, low-grade inflammation, myocarditis, obesity, insulin resistance, type 2 diabetes, adipose tissue macrophages, adipocytes, oxidative stress, mitochondrial dysfunction, endoplasmic reticulum stress, calcium handling, myocardial relaxation, myocardial fibrosis, cardiomyocyte injury, neurohormonal activation, diastolic dysfunction, systolic dysfunction
MeSH terms
Animals, Autophagy, Humans, Immunity, Innate, Inflammation, Cardiomyopathies, Myocardium, Prognosis, Signal Transduction, Inflammation Mediators

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inflammation and metabolic cardiomyopathy. https://app.cochat.ai/papers/10.1093/cvr/cvx012
The paper
Nishida, K., & Otsu, K. (2017). Inflammation and metabolic cardiomyopathy. Cardiovascular Research. https://doi.org/10.1093/cvr/cvx012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.